|
|
Volumn 337, Issue , 2008, Pages
|
|
News feature: Costly US anticancer drugs pose problems for doctors and patients.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
TRASTUZUMAB;
DRUG COST;
ECONOMICS;
FEE;
HUMAN;
NEOPLASM;
NOTE;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
DRUG COSTS;
HUMANS;
NEOPLASMS;
PRESCRIPTION FEES;
UNITED STATES;
|
|
EID: 47549110224
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.a778 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
